Investors

Building a Biopharmaceutical Company

Events

June 14th, 2014 - Lexicon presented the following data on LX4211 at the American Diabetes Association (ADA) meeting in San Francisco:

LX4211 Reduces Postprandial Glucose in Patients with Type 2 Diabetes Mellitus and Moderate to Severe Renal Impairment
LX4211 Improves Glycemic Control in NOD Mice with Type 1 Diabetes

June 3rd, 2014 - Webcast: Lexicon presents at the Jefferies 2014 Global Healthcare Conference at 9am, ET.

May 13, 2014: Webcast - Dr. Arthur Sands speaks at the Bank of America Merrill Lynch 2014 Health Care Conference, 1pm PDT.

May 8, 2014 - Webcast: Lexicon Pharmaceuticals First Quarter Earnings Call, 11am EDT.

April 14, 2014 - Webcast: Lexicon discusses the LX4211 Phase 2 Type 1 Diabetes Top-Line Clinical Trial Results at 8:30 a.m. EDT.  Please click here to access the webcast.

Register here to access the webcast

Register here to access the webcast

To access the webcast, please click HERE

To access the webcast, please click HERE

To access the webcast, please click HERE

To view the webcast, please click HERE

To view webcast, please click HERE

February 11, 2013 - Webcast: Lexicon to present at the Biotechnology Industry Organization 15th Annual BIO CEO & Investor Conference.  Click here to access the webcast.

January 9, 2013 - Webcast: Lexicon to present at the 31st Annual J.P. Morgan Healthcare Conference at 9:30 AM PST.  Click here to access the webcast.

View the slides

November 27, 2012 - Lexicon to present at Piper Jaffray 24th Annual Health Care Conference at 12:30 EST.  Click here to access the webcast.

November 13, 2012 - Webcast: Dr. Sands to present at the Jefferies 2012 Global Healthcare Conference at 3:40 PM GMT.  Click here to access the webcast.

November 6, 2012 - Lexicon reports on clinical program status and 2012 third quarter results at 11:00 a.m. Eastern Time.  Click here to access the webcast.

August 14, 2012 - Webcast:  Lexicon to present at Wedbush PacGrow 2012 Life Sciences Management Access Conference. Click here to access the webcast.

June 25, 2012 - Webcast:  Lexicon to discuss LX4211 Phase 2b top-line data. Click here to access the webcast.

June 9, 2012 - Lexicon presents LX4211 data at American Diabetes Association 72nd Scientific Sessions. Download poster #941, poster #974, poster #978, poster #991, poster #997 and poster #1137.

June 6, 2012 - Lexicon presents at the Jefferies Global Healthcare Conference at 11:00 a.m. Eastern Time. Click here to access the webcast.
May 21-22, 2012 - Lexicon presents LX1033 and telotristat etiprate data at Digestive Disease Week (DDW) in San Diego, CA. Download poster #1, poster #2, poster #3 and poster #4.
March 8, 2012 - Lexicon presents telotristat etiprate clinical data at European Neuroendocrine Society Annual Meeting at 11 a.m. CET (7 p.m. ET). Download poster #1 and poster #2.

October 22, 2011 - Lexicon presents LX1032 data at the North American NeuroEndocrine Tumor Society (NANETS) annual meeting in Minneapolis, Minnesota.

Download Poster #1  (603 KB)

Download Poster #2  (216 kb)

Download Presentation  (395 kb)

September 15, 2011 - Lexicon Presents LX4211 Data at European Association for the Study of Diabetes 2011 Conference. Click here to downloaded presentation.

June 6, 2011 - Lexicon Presents Poster at the 2011 American Society of Clinical Oncology (ASCO) annual meeting in Chicago, IL during the Trials in Progress Poster Session.
Download Poster  (472 kb)

May 25, 2011 - Phase 2a Data from Lexicon's Rheumatoid Arthritis Drug Candidate (LX2931) Presented at the European League Against Rheumatism (EULAR) Conference.
Download Presentation  (160 kb)

January 10, 2011 - Lexicon presents at JPMorgan Healthcare Conference at 10:30 a.m. Pacific Time. Click here to access the webcast.
October 22, 2010 - Lexicon presents at the BioCentury NewsMakers in the Biotech Industry Conference
September 16, 2010 - Lexicon Presents at Stifel Nicolaus Healthcare Conference

September 13, 2010 - Lexicon Presents at Morgan Stanley Global Healthcare Conference

August 28, 2010 - Lexicon Presents Phase 2 Results for Irritable Bowel Syndrome Drug Candidate (LX1031) at the 2010 Joint International Neurogastroenterology and Motility Meeting in Boston, Mass.
Download Presentation  (112 Kb)

June 11, 2010 - Lexicon Presents at Jefferies 2010 Global Life Sciences Conference.
June 9, 2010 - Lexicon Presents at the 9th Annual Needham Healthcare Conference.

May 2-5, 2010 - Lexicon Presents Phase 2 Results for IBS Drug Candidate, LX1031, at Digestive Disease Week (DDW) in New Orleans, LA
Download Poster  1.3 Mb
Download Presentation  161 Kb

November 25, 2009 - Lexicon presented positive Phase 2 results for LX1031 at GASTRO in London, UK.
Click here to view a webcast of the presentation.

November 13, 2009 - LX1031 Phase 2 Results Conference Call Audio Link
{audio}images/audio/lx1031_phase2_results_11-13-09.mp3{/audio}